期刊文献+

PTTG,c-myc和p53在非小细胞肺癌中的表达及意义 被引量:3

Expression of PTTG,c-myc and p53 gene in non-small cell lung carcinoma and its significance
下载PDF
导出
摘要 目的:探讨非小细胞肺癌(NSCLC)中PTTG,c-myc和p53的表达及其与NSCLC发生发展之间的关系。方法:用免疫组化法测定60例NSCLC标本及27例正常肺组织中PTTG,c-myc和p53的表达。结果:NSCLC组织细胞中PTTG,c-myc和p53的阳性表达率明显高于正常肺组织(P<0.01)。在不同组织学类型间阳性表达率差异无统计学意义(P>0.05),PTTG和c-myc在不同分化程度肺癌间的阳性表达率差异有统计学意义(P<0.05),淋巴结是否转移PTTG和c-myc的阳性表达率差异也有统计学意义(P<0.05)。PTTG与c-myc,PTTG与p53阳性表达率呈显著正相关(P<0.01),c-myc与p53阳性表达率也呈显著正相关(P<0.05)。结论:PTTG,c-myc和p53在NSCLC中有较高表达,有可能作为评估预后、指导治疗的指标。 Objective: To investigate the relationship between the expression of PTTG, c-myc and p53 and their role in occurance and development of non-small cell lung carcinoma. Methods: The expression of PTTG, c-myc and p53 was detected immunohistochemistrically in 60 cases of non-small cell lung carcinoma and 27 cases of normal lung tissue. Results: There was an extensive expression of PTTG, c-myc and p53 in tumor cell ( P 〈 0.01 ) ; difference was not found in groups of histology ( P 〉 0.05 ). The expression of PTTG and c-myc in tumor cell was both correlated with differentiated degree of lung cancer( P 〈0.05 ) ; in non-small cell lung carcinoma with lymph node metastasis, there was a significant difference ( P 〈 0.05 ) ; the positive expression of PTTG, c-myc and PTTG, p53 in non-small cell lung carcinoma had a striking positive correlation respectively(P 〈0.01 ). The positive expression of c-myc and p53 also had a striking positive correlation(P 〈0.05). Conclusion: The results indicate that PTTG, c-myc and p53 participate in occurrence and development of non-small cell lung carcinoma, and it may be the index of the prognosis appraisal and the therapeutic guidance.
出处 《江苏大学学报(医学版)》 CAS 2008年第2期131-134,共4页 Journal of Jiangsu University:Medicine Edition
关键词 非小细胞肺癌 垂体肿瘤转化基因 C-MYC P53 non-small cell lung carcinoma pituitary tumor transforming gene(PTYG) c-myc p53
  • 相关文献

参考文献4

二级参考文献22

  • 1田鸿生 刘铭球 等.建立动物肺癌模型的方法学研究Ⅱ.肺叶支气管内灌注致癌质碘油溶液诱发大白鼠肺癌的新方法[J].肿瘤防治研究,1982,9(1):2-2.
  • 2HEANEY AP, SINGSON R, MCCABE C J, et al. Expression of pituitary tumor-transforming geng in colorectal tumors [J]. Lancet,2000, 355: 716-719.
  • 3RAMOS--MORALES F, DOMINGUEZ A, ROMERO F, et al. Cell cycle regulated expression and phosphorylation of hpttg proto-oncoge be product[J]. Oncoge be, 2000, 19(3): 403-409.
  • 4YU IL REN SG, MELMED S, et al. Pituitary tumor-transforming geng(FITG) regulates piaeental JEG-3 cell division and survival:evidence from live cell immaging[J]. Mol Endocrinol, 2000, 14:1137-1146.
  • 5MCCABE CJ, GITTOES NJ. PTrG--a new pituitary tumor transforming gene [J]. J Endocrinol, 1999, 162: 163-166.
  • 6BENHARROCH D, YERMIAHU T, GEFFEN DB, et al. Expression of c-myc c-ras oneogenein the neoplastic and nonneoplastic cells of Hodykin,s disease[J]. Eur J Haematol, 1995,55(3): 178- 183.
  • 7PEI L Identification of c-myc as a down -stream target for PTTC.[J]. J Biol Chem, 2001, 276: 8484-8491.
  • 8DOMINGUEZ A, RAMOS-MORALES F, ROMERO F, et al.Hpttg, a human homologue of rat pttg, is overexpressioned in hematopoietie neoplasms[J]. Evidmce for a transcriptional activation function of Oncogene, 1998, 17: 2187-2193.
  • 9MITANI S, KAMATA H, FUJ-IWARA M, et al.Analysis of c-myc DNA amplification in non-small cell carcinoma in comparison with small cell lung carcinoma using polymerase chain reaction[J]. Clin Exp Med, 2001, 1(2):105-111.
  • 10PEI L, MELMED S. Isolation and characterization of a Pituitary tumor-transforming geng (PTTG) [J]. Mol Endocrinol, 1997, 11:433-441.

共引文献67

同被引文献31

  • 1陈艳,李建民.c-myc基因蛋白在交界性子宫平滑肌瘤中的表达及意义[J].山西医药杂志,2006,35(1):77-78. 被引量:2
  • 2陈龙,陈洁平.c-myc对肿瘤细胞生长抑制基因的转录调控[J].中华肿瘤防治杂志,2006,13(22):1752-1754. 被引量:14
  • 3Volm M,Koomagi R, Mattem J, et al. Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squarnous cell lung cancer[ J]. Int J Cancer, 1997, 74(1) :64 -68.
  • 4Perrot I, Blanchard D, Freymond N, et al. Dendritic cells infihrating human non-small cell lung cancer are blocked at immature stage [J].J Immunol, 2007, 178 (5) : 2763 - 2769.
  • 5Lechmann M,Berchtold S, Hauber J, et al. CD83 on dendritic cells: more than just a marker for maturation [ J ]. Trends Immunol, 2002,23 ( 6 ) : 273 - 275.
  • 6Morgunkova AA,Almazov VP, Strunina SM, et al. Dominant-negative inactivation of p53: the effect of the proportion between trans-dominant inhibitor and its target[J]. Mol Bio(Mosk) , 2003,37(1) : 112 - 120.
  • 7Lai H,Ma F, Trapido E, et al. Spectrum of p53 tumor suppressor gene mutations and breast cancer survival[J].Breast Cancer Res Treat,2004, 83 ( 1 ) : 57 - 66.
  • 8Pei L, Melmed S. Isolation and characterization of a pituitary tumor-transforming gene (PTTG) [J]. Mol Endocrinol, 1997,11 (4) :433-441.
  • 9Obaya A J, Mateyak M K, Sedivy J M. Mysterious liaisons: the relationship between C-myc and the cell cycle[J]. Oncogene, 1999,18(19)..2934-2941.
  • 10Nesbit C E, Tersak J M, Prochownik E V. Myc oncogene and human neoplastic disease [J]. Oncogene, 1999,18 (19): 3004- 3016.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部